Piramal Pharma Announces Completion of 20% Strategic Growth Investment by Carlyle
PEL raises funds of ~INR 14,500 Crores in FY2020
Built on the foundation of Trusteeship, Piramal Group imbibes a business ethos that believes in creating value for all its stakeholders.
Committed to its corporate philosophy of ‘Doing Well and Doing Good’, Piramal Group is focused on building innovative solutions that positively impact the larger community.
Delighted to partner with NITI Aayog and launch “Surakshit Dada Dadi Nana Nani Abhiyaan” in 112 Aspirational Districts across India
Piramal Retail Finance Expands Its Offerings; Enters Into Consumer And Used-Car Financing Segment Read More
Piramal Enterprises Appoints Khushru Jijina to its Board as Executive Director, Financial Services Read More
Piramal Pharma Ltd. To Acquire 100% Stake in Hemmo Pharmaceuticals, a Leading Indian Manufacturer of Peptide APIs Read More
Dr. Swati Piramal at ICBC Annual E Convention ‘LeaderSpeak’
CNBC TV-18 Big Deal | Nandini Piramal, Executive Director, Piramal Enterprises Ltd on Pharma Sector
Dr. Swati Piramal talks about women empowerment, Piramal Foundation, the Pharma industry, the 'New Normal' & much more in a 1:1 interaction on Zee Business' Navratri Special show with Swati Khandelwal.
Piramal Retail Finance, a business entity under Piramal Capital and Housing Finance Ltd., a subsidiary of PEL today announced the launch of its expanded multi-product retail financing platform.Read Here
Committed to providing excellence in pharma and financial services
World-class developments that nurture thriving communities
© 2021 Piramal Enterprises Ltd.